In a study using the high fat diet mouse model of NAFLD over 16 weeks, it was proposed that Anxa2 may contribute to lipid buildup and liver damage by inhibiting the autophagy flux controlled by AMPK-mTOR (40). Here, ANXA2 is linked to metabolic dysfunction-associated steatotic liver disease.